Literature DB >> 29664949

Correction: Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8.

Sun Jae Moon, Weon-Young Lee, Jin Seub Hwang, Yeon Pyo Hong, Donald E Morisky.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0187139.].

Year:  2018        PMID: 29664949      PMCID: PMC5903619          DOI: 10.1371/journal.pone.0196138

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The authors provide the following update to the Competing Interests statement: DEM holds a copyright for Morisky Medication Adherence Scale-8 (MMAS-8), is one of its authors, and collects fees in exchange for licenses to use this scale in research. This does not alter the authors’ commitment to objectivity in research and our adherence to PLOS ONE policies on sharing data and materials.
  1 in total

Review 1.  Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8.

Authors:  Sun Jae Moon; Weon-Young Lee; Jin Seub Hwang; Yeon Pyo Hong; Donald E Morisky
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

  1 in total
  2 in total

1.  Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison.

Authors:  Aki Kawakami; Makoto Tanaka; Lee Meng Choong; Reiko Kunisaki; Shin Maeda; Ingvar Bjarnason; Bu'Hussain Hayee
Journal:  Patient Prefer Adherence       Date:  2022-03-08       Impact factor: 2.711

2.  Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Stephen P Glasser; Mara Vitolins; Michael V Rocco; Carolyn Harmon Still; Stacey S Cofield; William E Haley; David Goff
Journal:  Am J Hypertens       Date:  2022-02-01       Impact factor: 2.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.